tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Mira Pharmaceuticals Inc

MIRA
Add to Watchlist
0.780USD
+0.030+4.01%
Close 08-14 16:00（ET）Quotes delayed by 15 min
32.79MMarket Cap
LossP/E TTM

Mira Pharmaceuticals Inc

0.780
+0.030+4.01%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

MIRA Financials

See Mira Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Mira Pharmaceuticals Inc Earnings Date

Latest Release
Aug 12, 2026
EPS / Forecast
-0.03/--
Revenue / Forecast
--/--
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.35
-165.61%
Analyst Rating
2026/08/14
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q1
FY2021Q1
Financial Indicators
EPS
68.23%-0.03
74.41%-0.03
-1.15%-0.15
-768.23%-1.18
20.89%-0.09
-22.96%-0.11
62.99%-0.14
48.45%-0.14
-33.26%-0.11
4.17%-0.09
---0.39
---0.26
---0.09
---0.09
----
----
----
Revenue
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
--0.00
Net Profit
21.41%-1.21M
35.52%-1.15M
-149.34%-5.98M
-1010.37%-22.69M
9.08%-1.54M
-3.84%-1.78M
58.54%-2.40M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
---5.79M
---3.59M
---1.27M
9.08%-1.34M
----
-2488.94%-1.48M
---56.98K
Debt to assets ratio
----
--0.00%
----
----
----
----
----
----
----
----
-100.00%0.00%
--0.00%
--47.13%
--55.22%
--15.51%
----
----
Income Statement
Revenue
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
--0.00
Operating profit
----
38.87%-1.10M
-138.94%-5.82M
36.73%-1.32M
10.67%-1.55M
-2.09%-1.81M
20.24%-2.44M
34.13%-2.08M
-78.38%-1.73M
-32.01%-1.77M
---3.06M
---3.16M
---970.22K
8.96%-1.34M
----
-2726.27%-1.47M
---52.05K
Net Profit
21.41%-1.21M
35.52%-1.15M
-149.34%-5.98M
-1010.37%-22.69M
9.08%-1.54M
-3.84%-1.78M
58.54%-2.40M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
---5.79M
---3.59M
---1.27M
9.08%-1.34M
----
-2488.94%-1.48M
---56.98K
Balance Sheet
Current assets
----
590.77%9.43M
282.95%11.06M
79.57%7.60M
-71.60%832.88K
-63.25%1.36M
-40.56%2.89M
-30.31%4.23M
597.00%2.93M
1379.29%3.71M
882.64%4.86M
--6.07M
--420.72K
-88.70%251.07K
--494.40K
--2.22M
----
Total current liabilities
----
8.09%114.76K
-2.94%702.07K
-87.89%83.93K
-62.53%298.46K
-83.72%106.17K
29.61%723.35K
-20.21%692.83K
-69.09%796.61K
-69.23%652.01K
-59.26%558.10K
--868.37K
--2.58M
296.59%2.12M
--1.37M
--534.26K
----
Total assets
844.72%8.20M
575.82%9.46M
279.52%11.09M
78.91%7.63M
-71.21%868.32K
-63.23%1.40M
-40.74%2.92M
-52.69%4.27M
-21.16%3.02M
857.99%3.81M
474.83%4.93M
--9.02M
--3.83M
-86.93%397.58K
--858.07K
--3.04M
----
Total liabilities
-86.32%40.82K
8.09%114.76K
-2.94%702.07K
-87.89%83.93K
-62.53%298.46K
-83.72%106.17K
29.61%723.35K
-23.27%692.83K
-69.69%796.61K
-70.19%652.01K
-61.62%558.10K
--902.90K
--2.63M
226.19%2.19M
--1.45M
--670.49K
----
Total equity
1332.34%8.16M
622.39%9.35M
372.40%10.39M
111.25%7.55M
-74.32%569.86K
-59.00%1.29M
-49.71%2.20M
-55.96%3.57M
85.44%2.22M
276.41%3.16M
833.67%4.37M
--8.12M
--1.20M
-175.50%-1.79M
---596.23K
--2.37M
----
Cash Flow Statement
Net operating income
-50.76%-1.21M
26.30%-1.20M
37.12%-1.14M
40.45%-1.10M
7.44%-799.65K
-55.31%-1.63M
-74.40%-1.81M
-4.59%-1.84M
-30.74%-863.93K
2.40%-1.05M
---1.04M
---1.76M
---660.81K
47.35%-1.08M
----
-12337.16%-2.04M
---16.42K
Net financing
-100.00%0.00
-9878.38%-330.61K
881.03%4.84M
-4.90%3.01M
103.65%323.84K
113.89%3.38K
313.83%493.40K
-58.41%3.16M
-76.76%159.01K
-103.35%-24.34K
---230.75K
--7.60M
--684.29K
-46.47%725.68K
----
7926.07%1.36M
--16.89K

FAQs

What are the current assets of Mira Pharmaceuticals Inc?

According to Mira Pharmaceuticals Inc's FY2025 earnings report, its current assets were 11.06M, with a year-on-year change of 282.95.

What are the total assets of Mira Pharmaceuticals Inc?

According to Mira Pharmaceuticals Inc's FY2025 earnings report, its total assets of Mira Pharmaceuticals Inc were 11.09M, with a year-on-year change of 279.52.

What are the total liabilities of Mira Pharmaceuticals Inc?

According to Mira Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Mira Pharmaceuticals Inc were 702.07K, with a year-on-year change of -2.94.

What is the total equity of Mira Pharmaceuticals Inc?

According to Mira Pharmaceuticals Inc's FY2025 earnings report, its total equity of Mira Pharmaceuticals Inc was 10.39M, with a year-on-year change of 372.40.

What is the net operating income of Mira Pharmaceuticals Inc?

According to Mira Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Mira Pharmaceuticals Inc was -10.49M, with a year-on-year change of -30.86.

What is the net financing of Mira Pharmaceuticals Inc?

According to Mira Pharmaceuticals Inc's FY2025 earnings report, its net financing of Mira Pharmaceuticals Inc was 8.18M, with a year-on-year change of 115.66.

What is the Earnings Per Share (EPS) of Mira Pharmaceuticals Inc?

According to Mira Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.35, with a year-on-year change of -165.61.

What is the net income of Mira Pharmaceuticals Inc?

According to Mira Pharmaceuticals Inc's FY2025 earnings report, its net income was -32.00M, with a year-on-year change of -307.50.

What is the Return on Equity (ROE) of Mira Pharmaceuticals Inc?

According to Mira Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -508.28, with a year-on-year change of -112.76.

What is the Return on Assets (ROA) of Mira Pharmaceuticals Inc?

According to Mira Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -149.00, with a year-on-year change of 25.47.

What is the operating profit of Mira Pharmaceuticals Inc?

According to Mira Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -10.49M, with a year-on-year change of -30.86.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy